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Abstract
In healthcare, a tremendous amount of clinical
and laboratory tests, imaging, prescription and
medication data are being collected. Big data
analytics on these data aim at early detection of
disease which will help in developing preventive
measures and in improving patient care. Parkinson
disease
is
the
second-most
common
neurodegenerative disorder in the United States. To
find a cure for Parkinson's disease biological,
clinical and behavioral data of different cohorts are
collected, managed and propagated through
Parkinson’s Progression Markers Initiative (PPMI).
Applying big data technology to this data will lead to
the identification of the potential biomarkers of
Parkinson’s disease. Data collected in human
clinical studies is imbalanced, heterogeneous,
incongruent and sparse. This study focuses on the
ways to overcome the challenges offered by PPMI
data which is wide and gappy. This work leverages
the initial discoveries made through descriptive
studies of various attributes. The exploration of data
led to identifying the significant attributes. We are
further working to build a software suite that enables
end to end analysis of Parkinson’s data (from
cleaning and curating data, to imputation, to
dimensionality reduction, to multivariate correlation
and finally to identify potential biomarkers).

1.Introduction
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Parkinson’s Disease (PD) is a neurodegenerative
disorder and millions of people suffer with it all over
the world. The incidence of PD increases with the
age growth, about 6.3 million people live with this
disease. Especially, in developed country, the number
of patients with PD has increased signiﬁcantly in
recent years. However, there are no methods which
can measure the PD progression efﬁciently and
accurately in its early stages [1]. The last known drug
for Parkinson’s disease was found in 1967.
Common symptoms in PD are muscular rigidity
(inflexibility of muscles), shivering (vibration in
upper and lower limbs or jaws), speech problem,
expressionless face, Bradykinesia (slow movements),
lethargy, postural instability (depression and
emotional changes), involuntary movements,
dementia (loss of memory), thinking inability and
sleeping disorders. Various stages of Parkinson’s
disease are,
 Primary - Due to unknown reasons

Secondary - Dopamine deficiency

Hereditary- Genetic origin
 Multiple system atrophy - Degeneration of
parts other than midbrain
For traditional PD assessment, Movement
Disorder Society-sponsored Uniﬁed Parkinson
Disease Rating Scale (MDS-UPDRS) is wildly used.
To better understand PD progression and to identify
potential biomarkers PPMI (Parkinson’s Progression
Markers Initiative) was set up. Clinical sites in the
United States, Europe, Israel and Australia contribute
to the comprehensive study. PPMI is funded by the
Micheal J. Fox Foundation. PPMI collects clinical,
biological and imaging data from multiple sites and
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disseminates it. This data is used to diagnose, track
and predict PD and its progression.
Parkinson’s data possess all the characteristics of
big data, which are characterized by volume, variety,
velocity, veracity, and value. From the context of
Parkinson’s data, these five Vs are further detailed as
below.
 Volume – With more and more attributes
being collected for the Parkinson’s research
and with the increase in participation of
different cohorts through various initiatives,
the volume of the data is growing.

Variety –Parkinson’s disease contains
structured, text, images, audio and semistructured data collected from the various
smart fitness tracking devices
 Velocity-Velocity is depicted by the speed
in which data is created, stored and
processed. Nowadays real-time processing
systems aid in real-time decision making.
 Veracity- Veracity deals with integrity of
data. Data quality issues and reliability of
the information are the key elements in
veracity. Parkinson’s data is heterogeneous,
multi-source, incomplete, incongruent and
sparse.
 Value- Extracting value from the data is the
goal of big data analytics.
The goal of working with the Parkinson’s data
from the public databases is to find potential
biomarkers thereby finding a cure for the disease.
Cleaning and curating data, however, to discover
patterns from it is very challenging [2].
The main contribution of this study is to identify
significant attributes that lead to PD. We first
grouped 1358 unique attributes to six major
categories. The data is then cleaned and curated.
Redundancy in attributes was removed. Out of 2600
attributes, only 1358 were unique attributes.
Descriptive studies of all these attributes were done.
We wish to answer several questions in our research
 How can we discover the potential
biomarkers of Parkinson’s disease by using
big data methodologies?
 Is it possible to use various machine
learning algorithms to help in early detection
of Parkinson’s disease?
 What are the data that needs to be analyzed
to discover the biomarkers of Parkinson’s
disease?
 How can we develop an interactive
visualization
that
helps
physicians
understand the relations between various



attributes that are a potential cause of
Parkinson’s disease?
Is it feasible to scale the visualization for
many user inputs? Does it yield the same
result as the initial visualization with the
training set?

In this study, we first tried understanding the
attributes and created a metadata of the attributes. We
did descriptive studies and computed the average of
PD and HC for all the attributes to identify significant
or important attributes. Curating the incomplete,
heterogeneous data has proven to be the biggest
challenge.

2. Related Work
In recent years, big data technologies are widely

used in healthcare for earlier diagnosis of diseases
and to provide better patient care. Dinov et al [3]
illustrated bigdata’s challenges and the role of big
data technology in the biomedical field. They explore
how the volume, variety, and velocity of biomedical
data have tremendously increased. The challenges
posed by biomedical data analysis is overcome by the
pipeline environment. The pipeline is a crowd-based
distributed solution for consistent management of
these heterogeneous resources. The pipeline allows
multiple (local) clients and (remote) servers to
connect, exchange protocols, control the execution,
monitor the states of different tools or hardware, and
share complete protocols as portable XML
workflows. As stated in their paper, Laboratory of
Neuro Imaging (LONI) is one such pipeline
environment for Parkinson’s big data research. LONI
seeks to improve understanding of the brain in health
and disease.
Big Data analytics is applied on data collected by
LONI from different sources. Machine learning
techniques help to predict the PD at an earlier stage.
Chen et al. [4] present an effective and efficient
diagnosis system using fuzzy k-nearest neighbor
(FKNN) for Parkinson’s disease (PD) diagnosis. The
proposed FKNN-based system is compared with the
support vector machines (SVM) based approaches.
To further improve the diagnosis accuracy for
detection of PD, principle component analysis was
employed. The effectiveness of the proposed system
has been rigorously estimated on a PD dataset in
terms of classification accuracy, sensitivity,
specificity and the area under the receiver operating
characteristic (ROC) curve. Experimental results
have demonstrated that the FKNN-based system
greatly outperforms SVM-based approaches and
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other methods in the literature. Gracy et al. [5] have
discussed the four types of classifiers namely, Naive
Bayes, Random tree, J48 and decision tree. Shivering
hands, legs, arms or jaws and emotional changes are
the factors considered in the study.
In the era of big data, the data quality is a big
challenge when applying machine learning
techniques and derive value from it. Ramentol et.al.
[6] have stated that imbalanced data is a common
problem in classification. Their paper proposes a new
hybrid method for preprocessing imbalanced datasets through the construction of new samples, using
the Synthetic Minority Oversampling Technique
together with the application of an editing technique
based on the Rough Set Theory and the lower
approximation of a subset. The proposed method has
been validated by an experimental study showing
good results using C4.5 as the learning algorithm.
Cho et al. [7] proposed a system for combining
principal component analysis (PCA) with linear
discriminant analysis (LDA). They proposed a gait
analysis system which can detect the gait pattern of
Parkinson’s disease using computer vision. Dinov et
al.
[8] introduces methods for rebalancing
imbalanced cohorts and utilizes a wide spectrum of
classification methods to generate consistent and
powerful phenotypic predictions. It generates
reproducible machine learning based classification
that enables the reporting of model parameters and
diagnostic forecasting based on new data.
Data collected in clinical studies is complex. Data
visualization is paramount to enhance the
understanding of data. Maciejewski et al. [9] have
provided visual analytics systems to users to explore
trends in their data. Linked views and interactive
displays provide insight into correlations among
people, events, and places in space and time.
Furthermore, this study helps facilitate forecasting, as
it has created a predictive visual analytics toolkit that
provides researchers with linked spatiotemporal and
statistical analytic views. Though there are several
machine learning algorithms that have been
implemented on different datasets on Parkinson there
is no software developed to visually explore the
correlations among various attributes and PD
progression. Our study aims to visualize the risk
factors and their relationship to PD.

3.Research Goals
Data collected from PPMI study consists of
clinical, biological and imaging data of various
patients. There are 2600 attributes and the number is
constantly increasing as it is an ongoing study. This

paper addresses the general challenges of data
curation, munging, aggregation, and preliminary
descriptive analyses of the PPMI data. This paper
provides the results of the preliminary analyses.
Cleaning and curating the data is the biggest
challenge. Each file was taken individually,
redundant and administrative data that was not
required for the study was removed. Aggregating
these wide attributes together creates a huge sparse
matrix. Finding the correlation between various
attributes and visualizing them is the goal of this
paper. Merits – This framework with a simple
interactive visualization will abstract people from
sophisticated mathematics to provide a simplified and
understandable version of the disease to the life style
of a common man.
After doing the initial analysis we have
formulated two long term objectives for our study.
Long term objective 1 focuses on tools for curating
and imputing missing data using a set of novel
algorithms.
Long term objective 2 consists of tools for
reducing the dimensionality of the post-imputation
data. End-users may effortlessly deploy several
dimensionality reduction strategies, visually explore,
and pick the most insightful approach.

4. Data
The PPMI study dataset is disseminated by PPMI
Bioinformatics Core at the University of Southern
California. This database includes clinical, biological
and imaging data collected at various participating
sites. PPMI also collects biologic specimens
including urine, plasma, serum, cerebrospinal fluid,
DNA, and RNA. The complete PPMI data set
includes Biospecimen (ex: Lab reports, Blood
sample), Imaging, Medical History, Subject
Characteristics
(ex:
Demographics),
Motor
Assessment, and Non-Motor Assessment.
Table 1. Details of Files in PPMI
No of Files (CSV/Tables)
No of Files containing Administrative
Data
No of Files containing Clinical,
Questionnaire data

92
12
80

Table 2. Details of Various Attributes in PPMI
Total Number of Attributes

2600

Total Number of Unique Attributes

1358
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Numerical Attributes

779

Categorical Attributes

1316

Time

47

Date

458

The dataset obtained from PPMI for our study
consists of 1479 patients. PD are patients with
Parkinson’s disease and 418 PD patients were
considered in our study. Healthy control (HC) was
172 in number. We considered 418 PD, 172 HC and
62 Prodromal patients (In medicine, a prodrome is an
early sign or symptom or set of signs and symptoms,
which often indicate the onset of a disease before
more diagnostically specific signs and symptoms
develop). These totals up to 652 out of 1479 patients.
The remaining 827 are genetic cohorts and genetic
registry patients will be considered in the future
research. Genetic Cohort PD, Genetic Cohort
Unaffected, Genetic Registry PD, and Genetic
Registry Unaffected are the other Cohorts in the
dataset, but these cohorts were not included in the
current study.

sleepiness scale are some of the non-motor
assessment tests).
Figure 1 is visual representation of the file and its
category. This categorization helps us understand the
attributes better on a high level.
Table 4. Details of Various Data Categories
after Data was Analyzed and Cleaned
Category

Number of Files

Biospecimen

11

Imaging

9

Medical History

14

Motor Assessment

11

Non-Motor Assessment

16

Subject Characteristics

5

Table 3. Details of Patient Status
HC - Healthy Control

172

PD - Parkinson's Disease

418

4.1. Data Categorization
Data from various files are categorized into six
major categories such as
a)
Biospecimen (ex: Lab reports, Blood sample),
b)
Imaging (ex: DaTscan imaging, Magnetic
Resonance Imaging)
c)
Medical History (ex: General medical history,
General neurological exam, General physical
exam, Pregnancy forms, Neurological exam
cranial nerves)
d)
Subject Characteristics (ex: demographics,
PPMI took place at clinical sites in the United
States, Europe, Israel, and Australia),
e)
Motor Assessment (ex: assessment of tremor
with bradykinesia, assessment of tremors in
tongue, jaw, lower lip, hand or in the leg/foot.
Movement Disorder Society (MDS) offers
Unified Parkinson’s Disease Rating Scale
(UPDRS) which guides in the motor
assessment), and
f)
Non-Motor Assessment (ex: assessment of
verbal learning, semantic fluency and

Figure 1. Data Categories

5. Analyses and Findings
The individual data files were cleaned and
redundant data were removed. Out of initial 92
files(as mentioned in table 1) , only 66 files (as
mentioned in table 4) contained the features
associated with Parkinson’s disease.
The
administrative data about the enrollment status of
different cohorts were excluded. The final list after
removing the redundant and administrative attributes
had 978 attributes. A descriptive study of all
attributes was done. Mean, median, minimum,
maximum, mode and standard deviation of all the
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978 attributes were calculated. After the preliminary
data exploration, we studied the correlation of
different attributes with the patient status.
Data was mapped to the same standardized
names. (ex: Some files had attributes called subject id
and some had attributes called Patient Number).
Once the data was standardized. All the data was
loaded into PostgreSQL database. The data model of
the database has the six main categories such as
biospecimen, imaging, motor assessment, non-motor
assessment,
medical
history
and
subject
characteristics.
Metadata file containing the information about
the data was created.

Figure 2. A High-Level Overview of the Data
Model
All the data from PPMI after cleaning was loaded
into a PostgreSQL database. Figure 2 gives a high
level data model of the database. This indicates how
the tables were created and data was loaded.

5.1. Significant Attributes
Once all the attributes are aggregated, the average
value for Parkinson’s disease PD and healthy control
HC cohort was calculated. The difference in the value
was normalized. Figure 3 illustrates how the average
value of PD and HC appear after normalization. The
values are between 0 and 1 and easy to compare. The
difference in value was visualized in Tableau which
was connected to the database as illustrated in figure
4. The attributes with a significant difference in value
were identified. In a high dimensional dataset
discovering the important features is crucial. The
study results demonstrated the attributes in
MDS_UPDRS_Part_III had the significant attributes.

Figure 3. Normalized Data

Figure 4. Attributes with Significant
Difference between PD and HC Values.
We also, explored the correlations among the
attributes using circos visualizations. See figure 5.
Circos visualization is an interactive tool in that we
can isolate the relationship between one attribute and
all other attributes, displaying the strength of the
correlation as a measure of the width of the flare. An
interactive version will be provided later.

Figure 5. Circos Visualization with
Significant Attributes.
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Currently, data from clinical and behavioral
studies of PD are growing rapidly and with little
knowledge or coordination of attributes collected.
Understanding the importance of each attribute
collection to PD detection and treatment is important
and our work helps highlight the challenges in data
quality and tools to improve the same. Future work
can be extended by allowing researchers to add
additional attributes and determine their role in PD.

8. Reference:

Figure 6. Circos Visualization Displaying
Correlation between Attributes.
Figure 6. illustrates how UPDRS (Unified
Parkinson’s Disease Rating Scale) is highly
correlated with bradykinesia, postural instability,
hallucination and speech. Furthermore, the graph is
interactive as we can hover-over the visualization to
find the correlations of any other attributes with
others.

6. Challenges in Dataset
The dataset from PPMI is wide with 2600
attributes. The complexity is furthermore increased as
it is a time series data. Curating and stacking the data
is a big challenge. The data is incomplete,
imbalanced and incompatible. When data is
aggregated together there are lots of missing value.
Only 30% of data is available. Imputing the
missing value is of paramount importance for
implementing various machine learning algorithms
on the data to identify the potential biomarkers.
To overcome the challenges posed by human
clinical datasets we are researching on a set of novel
algorithms. (a) Singular Value Decomposition type
imputation, (b) gappy Tensor decomposition, and (c)
standard knn based imputation. The latter approach,
prevalent in biomedical research, will serve as a
benchmark. The two former methods (especially the
Tensor decomposition) have shown phenomenal
ability to impute complex datasets in engineering
problems and will translate into novel approaches for
biomedical data.
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